These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

697 related items for PubMed ID: 17465211

  • 21. Combined evaluation of dihydropyrimidine dehydrogenase and thymidine phosphorylate mRNA levels in tumor predicts the histopathological effect of 5-fluorouracil-based chemoradiotherapy.
    Tateishi Y, Tatemoto Y, Ohno S, Morishita K, Ueta E, Yamamoto T.
    Cancer Lett; 2009 Feb 18; 274(2):187-93. PubMed ID: 18986760
    [Abstract] [Full Text] [Related]

  • 22. Immunohistochemical demonstration of fluoropyrimidine-metabolizing enzymes in various types of cancer.
    Kamoshida S, Shiogama K, Shimomura R, Inada K, Sakurai Y, Ochiai M, Matuoka H, Maeda K, Tsutsumi Y.
    Oncol Rep; 2005 Nov 18; 14(5):1223-30. PubMed ID: 16211289
    [Abstract] [Full Text] [Related]

  • 23. [Correlation between 5-fluorouracil (5-FU) sensitivity as measured by collagen gel droplet embedded culture drug sensitivity test (CD-DST) and expression of orotate phosphoribosyl transferase (OPRT), thymidylate synthase (TS), and dihydropyrimidine dehydrogenase (DPD) in colorectal cancer].
    Ochiai T, Sugitani M, Nishimura K, Noguchi H, Watanabe T, Sengoku H, Kihara A, Okano M.
    Gan To Kagaku Ryoho; 2001 May 18; 28(5):661-7. PubMed ID: 11383215
    [Abstract] [Full Text] [Related]

  • 24. The expression profiles of orotate phosphoribosyltransferase and dihydropyrimidine dehydrogenase in gastric cancer and their clinical significance.
    Oeda M, Yoshida K, Sanada Y, Wada Y, Suzuki T, Mizuiri H, Konishi K, Shigematsu H, Tanabe K, Fukushima M.
    Oncol Rep; 2006 Dec 18; 16(6):1165-72. PubMed ID: 17089033
    [Abstract] [Full Text] [Related]

  • 25. Relationship between gene expression of 5-fluorouracil metabolic enzymes and 5-fluorouracil sensitivity in primary cancer cells isolated from malignant ascites.
    Wang T, Wang L, Qian X, Yu L, Ding Y, Liu B.
    Cancer Invest; 2011 Feb 18; 29(2):130-6. PubMed ID: 21210725
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Thymidylate synthase and dihydropyrimidine dehydrogenase mRNA expression levels: predictors for survival in colorectal cancer patients receiving adjuvant 5-fluorouracil.
    Kornmann M, Schwabe W, Sander S, Kron M, Sträter J, Polat S, Kettner E, Weiser HF, Baumann W, Schramm H, Häusler P, Ott K, Behnke D, Staib L, Beger HG, Link KH.
    Clin Cancer Res; 2003 Sep 15; 9(11):4116-24. PubMed ID: 14519634
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. [Prediction of sensitivity to 5-fluorouracil (5-fu) by metabolic and target enzyme activities in colon cancer].
    Yamada T, Tanaka N, Yokoi K, Ishikawa N, Seya T, Horiba K, Kanazawa Y, Shirakawa T, Ohkawa K, Kudoh H, Koizumi M, Yoshioka M, Shinji S, Yamashita K, Tajiri T.
    Gan To Kagaku Ryoho; 2006 Nov 15; 33(11):1603-9. PubMed ID: 17108726
    [Abstract] [Full Text] [Related]

  • 32. Correlation between thymidylate synthase and dihydropyrimidine dehydrogenase mRNA level and in vitro chemosensitivity to 5-fluorouracil, in relation to differentiation in gastric cancer.
    Fakhrejahani E, Miyamoto A, Tanigawa N.
    Cancer Chemother Pharmacol; 2007 Aug 15; 60(3):437-46. PubMed ID: 17377791
    [Abstract] [Full Text] [Related]

  • 33. Orotate phosphoribosyl transferase mRNA expression and the response of cholangiocarcinoma to 5-fluorouracil.
    Hahnvajanawong C, Chaiyagool J, Seubwai W, Bhudhisawasdi V, Namwat N, Khuntikeo N, Sripa B, Pugkhem A, Tassaneeyakul W.
    World J Gastroenterol; 2012 Aug 14; 18(30):3955-61. PubMed ID: 22912546
    [Abstract] [Full Text] [Related]

  • 34. Effects of tumor necrosis factor-related apoptosis-inducing ligand alone and in combination with fluoropyrimidine anticancer agent, S-1, on tumor growth of human oral squamous cell carcinoma xenografts in nude mice.
    Itashiki Y, Harada K, Ferdous T, Yoshida H.
    Anticancer Res; 2007 Aug 14; 27(4B):2365-75. PubMed ID: 17695527
    [Abstract] [Full Text] [Related]

  • 35. Analysis of 5-fluorouracil-related enzymes in pulmonary neuroendocrine carcinoma: differences in biological properties compared to epithelial carcinoma.
    Nagasaki T, Tsuchiya T, Tagawa T, Honda S, Yamasaki N, Miyazaki T, Hidaka S, Hayashi T, Nagayasu T.
    Clin Lung Cancer; 2010 Nov 01; 11(6):412-22. PubMed ID: 21062732
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Thymidine phosphorylase, dihydropyrimidine dehydrogenase and thymidylate synthase mRNA expression in primary colorectal tumors-correlation to tumor histopathology and clinical follow-up.
    Lassmann S, Hennig M, Rosenberg R, Nährig J, Schreglmann J, Krause F, Poignee-Heger M, Nekarda H, Höfler H, Werner M.
    Int J Colorectal Dis; 2006 Apr 01; 21(3):238-47. PubMed ID: 16132996
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical role of orotate phosphoribosyl transferase and dihydropyrimidine dehydrogenase in colorectal cancer treated with postoperative fluoropyrimidine.
    Tokunaga Y, Sasaki H, Saito T.
    Surgery; 2007 Mar 01; 141(3):346-53. PubMed ID: 17349846
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 35.